Wednesday, June 21, 2017 10:50:40 AM
BOTTOM-LINE FINANCIAL BELOW EXCERPT FROM 6-5-17 PR AS FOLLOWS:
Gross Revenue:
Q1 2016 – $1,535,728
Q1 2017 – $3,612,739
Gross Profit:
Q1 2016 – $820,446
Q1 2017 – $2,545,229
Net Income/Loss:
Q1 2016 – ($11,096,659)
Q1 2017 – ($2,222,818)
Net Comprehensive Income:
Q1 2016 – ($9,708,598)
Q1 2017 – $105,632,830
Total assets:
Q1 2016 – $214,115,665
Q1 2017 – $494,182,096
"The stock market is a device for transferring money from the impatient to the patient" — Warren Buffett
"The Big Money is not in the buying and the selling but in the waiting" — Charlie Munger
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM